Journals 2024
Publications menu
A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma.
International Journal of Radiation Oncology, Biology, Physics.
2024,
120(3),
738-749,
ISSN: 0360-3016,
PMID: 38768767,
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Hematological Oncology.
2024,
42(3),
e3280,
ISSN: 0278-0232,
PMID: 38741354,